[go: up one dir, main page]

Fessart, 2006 - Google Patents

Regulation of the endocytic adaptor proteins farrestin and AP-2 during clathrin-mediated internalization of

Fessart, 2006

View PDF
Document ID
9011109046046056031
Author
Fessart D
Publication year

External Links

Snippet

ABSTRACT G protein-coupled receptors (GPCRs) are the largest family of cell-surface receptors. They transduce the signals mediated by a diverse range of signalling molecules, including ions, amines, and peptides, as well as photons, to mediate intracellular functions …
Continue reading at www.collectionscanada.gc.ca (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Similar Documents

Publication Publication Date Title
Rajagopal et al. GPCR desensitization: Acute and prolonged phases
Grady et al. Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors
Kara et al. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for β-arrestin-mediated ERK activation
Groer et al. Agonist-directed interactions with specific β-arrestins determine μ-opioid receptor trafficking, ubiquitination, and dephosphorylation
Fessart et al. c-Src regulates clathrin adapter protein 2 interaction with β-arrestin and the angiotensin II type 1 receptor during clathrin-mediated internalization
Guillaume et al. The PDZ protein mupp1 promotes Gi coupling and signaling of the Mt1 melatonin receptor
Hanono et al. EPI64 regulates microvillar subdomains and structure
Chowdhury et al. Tyrosine phosphorylation regulates the endocytosis and surface expression of GluN3A-containing NMDA receptors
EP3194960B1 (en) Biosensors for monitoring biomolecule localization and trafficking in cells
Simaan et al. Dissociation of β-arrestin from internalized bradykinin B2 receptor is necessary for receptor recycling and resensitization
Nisar et al. Arrestin scaffolds NHERF1 to the P2Y12 receptor to regulate receptor internalization
Georgoussi et al. The other side of opioid receptor signalling: regulation by protein-protein interaction
Cotecchia et al. Protein-protein interactions at the adrenergic receptors
Kim et al. Interactions with filamin A stimulate surface expression of large-conductance Ca2+-activated K+ channels in the absence of direct actin binding
Niedernberg et al. Regulated and constitutive activation of specific signalling pathways by the human S1P5 receptor
Fessart Regulation of the endocytic adaptor proteins farrestin and AP-2 during clathrin-mediated internalization of
Fessart Regulation of the endocytic adaptor proteins [beta] arrestin and AP-2 during clathrin-mediated internalization of Angiotensin II type 1 receptor
TW200934789A (en) Complexes of TRPC domains and SESTD1 domains and methods and uses involving the same
Shenoy β-arrestin-biased signaling by the β-adrenergic receptors
EP1865320A2 (en) Cellular antanonist
Schulz et al. Effect of phosducin on opioid receptor function
Schmid et al. βArrestins: ligand-directed regulators of 5-HT2A receptor trafficking and signaling events
Fessart et al. c-Src regulates AP-2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin-mediated internalization
Wysolmerski Elucidating the subcellular organization of endogenous G protein activation by GPCRs
Houri Study of ERK12 MAP kinases activation by the bradykinin type 2 receptor: characterization of beta-arrestin scaffolding function in the temporal regulation of ERK12 activation induced by the B2R